| Balance Sheets | 2025-03-31 | |||
|---|---|---|---|---|
| Property and equipment, gross | 432,523 | |||
| Less accumulated depreciation | 430,919 | |||
| Property and equipment, net | 1,604 | |||
| Inventories | 1,750,121 | |||
| Prepaid expenses and other current assets | 0 | |||
| Note receivable | 41,916 | |||
| Cash | 68,489 | |||
| Accounts receivable, net | 60,985 | |||
| Total current assets | 1,921,511 | |||
| Investments | 4,539 | |||
| Goodwill | 570,176 | |||
| Total assets | 2,497,830 | |||
| Notes payable | 805,422 | |||
| Total long-term liabilities | 805,422 | |||
| Notes payable | 135,411 | |||
| Line of credit | 311,273 | |||
| Customer deposit | 302,607 | |||
| Convertible notes payable, net of debt discount | 144,000 | |||
| Accrued compensation - officers | 13,000 | |||
| Accrued liabilities | 1,111,480 | |||
| Accounts payable - related party | 0 | |||
| Accounts payable | 252,645 | |||
| Note payable to shareholder | 104,512 | |||
| Total current liabilities | 2,374,928 | |||
| Total liabilities | 3,180,350 | |||
| Accumulated deficit | -20,307,784 | |||
| Preferred stock, series a, 0.0001 par value, 10,000 shares authorized, 2,006 and 2,006, issued and outstanding | 2,006,000 | |||
| Common shares to be issued (593,556 shares) | 87,362 | |||
| Common stock, 0.0001 par value 100,000,000 shares authorized, 58,930,204 and 52,712,778 shares issued and outstanding | 5,893 | |||
| Additional paid in capital | 17,526,009 | |||
| Total shareholders equity | -682,520 | |||
| Total liabilities and shareholders equity | 2,497,830 | |||
US NUCLEAR CORP. (UCLE)
US NUCLEAR CORP. (UCLE)